PIQ - Proteomics International continuing its rapid climb
Good little stock with lots of momentum. All my indicators are headed in the right direction - probably a bit expensive at the moment based on the RSI - but with diabetes being the next big global disease especially in the western world Ill take a punt and hold for the medium to long term unless a sudden significant reversal.
Todays announement was: "Proteomics signs collaboration agreement with US big pharma to accelerate diabetic kidney disease & heart disease drug discovery using PromarkerD"
Proteomics International Laboratories Limited is a biological research and drug discovery company. The Company operates in three business units unified by a technology platform: Analytical services, which includes specialist contract research, analytical testing and consultancy; Diagnostics, which includes biomarkers of disease and personalized medicine, and Therapeutics, which includes peptide drug discovery from venoms. The Company focuses on the PromarkerD, a proteomics-derived predictive and diagnostic test for diabetic kidney disease. The Company focuses on its diagnostics portfolio using the Promarker platform, and is investigating proteins associated with endometriosis, mesothelioma and other conditions. The Company has a therapeutic drug discovery program targeting new analgesic (painkilling) and antibiotic drug compounds. The Company also has a laboratory to analyze the make-up of biosimilar drugs as being like-for-like with the brand name drugs they seek to replace.